Drugs / umbilical cord mesenchymal stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02961725 | Apr 2016 → Apr 2017 | — | The Second Affiliated Hospital of Fujian Medical University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | umbilical cord mesenchymal stem cells | “UCMSC: umbilical cord mesenchymal stem cells 3-5\*10\^7/5 ml” NCT02961725 ↗ |
| Known as | UCMSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02961725 ↗ |
| Modality | Cell therapy | “umbilical cord mesenchymal stem cells” NCT02961725 ↗ |
| Route | Other | “conduct endoscopic injection of umbilical cord mesenchymal stem cells to fistula” NCT02961725 ↗ |